FASLODEX
Generic Name/API: fulvestrant
Manufacturer: AstraZeneca
Dosage Forms & Strength:
FASLODEX, an injection for intramuscular administration, is supplied as 250 mg/5 mL fulvestrant.
Storage:
REFRIGERATE, 2°-8°C (36°-46°F). TO PROTECT FROM LIGHT, STORE IN THE ORIGINAL CARTON UNTIL TIME OF USE.
What is Faslodex?
Faslodex is an anti-estrogen medication. It works by blocking the actions of estrogen in the body. Certain types of breast cancer use estrogen to grow and multiply in the body.
Faslodex is used in postmenopausal women with hormone-related breast cancer that is advanced or has spread to other parts of the body (metastatic).
Faslodex is used alone or in combination with another medicine called ribociclib (Kisqali) to treat HR-positive, HER2-negative breast cancer in:
- women with no prior treatment; or
- women whose cancer has progressed after treatment with anti-estrogen medication.
Faslodex is used in combination with palbociclib (Ibrance) or abemaciclib (Verzenio) when the cancer has progressed after treatment with anti-estrogen medication.
Warnings
You should not receive Faslodex if you are pregnant.
Avoid getting pregnant or breast-feeding a baby for at least 1 year after you stop using this medicine.
Before you receive Faslodex, tell your doctor if you have liver disease, a bleeding or blood-clotting disorder, or thrombocytopenia (a low level of platelets in the blood). Also tell your doctor if you are taking a blood thinner such as warfarin (Coumadin, Jantoven).
Call your doctor for instructions if you miss an appointment for your injection.
You should not be treated with Faslodex if you are allergic to fulvestrant, or if you are pregnant.
Tell your doctor if you have ever had:
- liver disease;
- bleeding problems; or
- thrombocytopenia (a low level of platelets in the blood).
You may need to have a negative pregnancy test 7 days before starting this treatment.
Fulvestrant may harm an unborn baby. Use effective birth control to prevent pregnancy while using this medicine and for at least 1 year after your last dose. Tell your doctor right away if you become pregnant during this time.
Faslodex may affect fertility (ability to have children) in both men and women. However, it is important for women to use birth control to prevent pregnancy because fulvestrant can harm an unborn baby.
Do not breastfeed while using Faslodex, and for at least 1 year after your last dose.
*The contents of this site are for reference only. We do not offer drug procurement service. All information must not be used for any commercial purpose.
